Woodline Partners’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.9M Sell
1,000,428
-648,000
-39% -$41.2M 0.25% 93
2025
Q4
$105M Buy
1,648,428
+703
+0% +$43.7K 0.41% 43
2025
Q3
$90.6M Buy
1,647,725
+1,435,422
+676% +$59.1M 0.43% 48
2025
Q2
$7.01M Hold
212,303
0.04% 499
2025
Q1
$8.53M Buy
212,303
+86,102
+68% +$3.96M 0.06% 390
2024
Q4
$5.94M Sell
126,201
-2,834
-2% -$147K 0.04% 453
2024
Q3
$6.81M Sell
129,035
-69,146
-35% -$3.85M 0.06% 349
2024
Q2
$10.7M Buy
+198,181
New +$12M 0.1% 241
2024
Q1
Sell
-42,652
Closed -$3.56M 561
2023
Q4
$3.56M Buy
+42,652
New +$1.54M 0.04% 347

Other funds holding CYTK